International Assets Investment Management LLC Buys 24,779 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

International Assets Investment Management LLC lifted its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 910.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,502 shares of the company’s stock after acquiring an additional 24,779 shares during the period. International Assets Investment Management LLC owned 0.52% of VanEck Pharmaceutical ETF worth $2,238,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Bank of America Corp DE increased its position in VanEck Pharmaceutical ETF by 161.4% during the 1st quarter. Bank of America Corp DE now owns 778,144 shares of the company’s stock valued at $60,407,000 after buying an additional 480,478 shares in the last quarter. Goldman Sachs Group Inc. increased its position in VanEck Pharmaceutical ETF by 144.5% during the 2nd quarter. Goldman Sachs Group Inc. now owns 359,687 shares of the company’s stock valued at $27,638,000 after buying an additional 212,560 shares in the last quarter. JPMorgan Chase & Co. increased its position in VanEck Pharmaceutical ETF by 284.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 203,189 shares of the company’s stock valued at $16,227,000 after buying an additional 150,365 shares in the last quarter. Miller Investment Management LP increased its position in VanEck Pharmaceutical ETF by 4,444.9% during the 2nd quarter. Miller Investment Management LP now owns 144,983 shares of the company’s stock valued at $11,420,000 after buying an additional 141,793 shares in the last quarter. Finally, Jane Street Group LLC acquired a new position in VanEck Pharmaceutical ETF during the 2nd quarter valued at about $4,464,000.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ:PPH opened at $85.14 on Friday. The business’s 50-day moving average is $88.78 and its 200 day moving average is $83.41. The firm has a market capitalization of $501.47 million, a P/E ratio of 20.57 and a beta of 0.49. VanEck Pharmaceutical ETF has a 1 year low of $74.05 and a 1 year high of $91.16.

VanEck Pharmaceutical ETF Announces Dividend

The company also recently declared a dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, April 2nd were paid a dividend of $0.5328 per share. The ex-dividend date of this dividend was Monday, April 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.